170 related articles for article (PubMed ID: 6327758)
1. The new steroid analog RU 486 inhibits glucocorticoid action in man.
Bertagna X; Bertagna C; Luton JP; Husson JM; Girard F
J Clin Endocrinol Metab; 1984 Jul; 59(1):25-8. PubMed ID: 6327758
[TBL] [Abstract][Full Text] [Related]
2. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
[TBL] [Abstract][Full Text] [Related]
3. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
[TBL] [Abstract][Full Text] [Related]
4. Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome.
Bertagna X; Bertagna C; Laudat MH; Husson JM; Girard F; Luton JP
J Clin Endocrinol Metab; 1986 Sep; 63(3):639-43. PubMed ID: 3734034
[TBL] [Abstract][Full Text] [Related]
5. Transient inhibition of RU 486 antiglucocorticoid action by dexamethasone.
Raux-Demay MC; Pierret T; Bouvier d'Yvoire M; Bertagna X; Girard F
J Clin Endocrinol Metab; 1990 Jan; 70(1):230-3. PubMed ID: 2152931
[TBL] [Abstract][Full Text] [Related]
6. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.
Gaillard RC; Riondel A; Muller AF; Herrmann W; Baulieu EE
Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3879-82. PubMed ID: 6328529
[TBL] [Abstract][Full Text] [Related]
7. Increased adrenocorticotropin, cortisol, and arginine vasopressin secretion in primates after the antiglucocorticoid steroid RU 486: dose response relationships.
Healy DL; Chrousos GP; Schulte HM; Gold PW; Hodgen GD
J Clin Endocrinol Metab; 1985 Jan; 60(1):1-4. PubMed ID: 2981083
[TBL] [Abstract][Full Text] [Related]
8. RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.
Garrel DR; Moussali R; De Oliveira A; Lesiège D; Larivière F
J Clin Endocrinol Metab; 1995 Feb; 80(2):379-85. PubMed ID: 7888013
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects.
Laue L; Lotze MT; Chrousos GP; Barnes K; Loriaux DL; Fleisher TA
J Clin Endocrinol Metab; 1990 Dec; 71(6):1474-80. PubMed ID: 2172280
[TBL] [Abstract][Full Text] [Related]
10. Effects of the glucocorticoid antagonist RU 486 on pituitary-adrenal function in patients with anorexia nervosa and healthy volunteers: enhancement of plasma ACTH and cortisol secretion in underweight patients.
Kling MA; Demitrack MA; Whitfield HJ; Kalogeras KT; Listwak SJ; DeBellis MD; Chrousos GP; Gold PW; Brandt HA
Neuroendocrinology; 1993 Jun; 57(6):1082-91. PubMed ID: 8232766
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the ACTH response to human CRH by pretreatment with the antiglucocorticoid RU-486.
Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
Eur J Clin Pharmacol; 1987; 31(5):609-11. PubMed ID: 3030764
[TBL] [Abstract][Full Text] [Related]
12. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
[TBL] [Abstract][Full Text] [Related]
13. [Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
Gaillard RC; Herrmann W
Ann Endocrinol (Paris); 1983; 44(5):345-6. PubMed ID: 6675522
[TBL] [Abstract][Full Text] [Related]
14. Effects of the antiglucocorticoid RU 486 on adrenal function in dogs.
Wade CE; Spitz IM; Lahteenmaki P; Heikinheimo O; Krieger DT; Bardin CW
J Clin Endocrinol Metab; 1988 Mar; 66(3):473-9. PubMed ID: 2832437
[TBL] [Abstract][Full Text] [Related]
15. The antiglucocorticoid and antiprogestin steroid RU 486: its glucocorticoid agonist effect is inadequate to prevent adrenal insufficiency in primates.
Laue L; Gallucci W; Loriaux DL; Udelsman R; Chrousos GP
J Clin Endocrinol Metab; 1988 Sep; 67(3):602-6. PubMed ID: 2842364
[TBL] [Abstract][Full Text] [Related]
16. RU 486 inhibits peripheral effects of glucocorticoids in humans.
Gaillard RC; Poffet D; Riondel AM; Saurat JH
J Clin Endocrinol Metab; 1985 Dec; 61(6):1009-11. PubMed ID: 4055982
[TBL] [Abstract][Full Text] [Related]
17. The hormonal actions of corticotropin-releasing factor in sheep: effect of intravenous and intracerebroventricular injection.
Donald RA; Redekopp C; Cameron V; Nicholls MG; Bolton J; Livesey J; Espiner EA; Rivier J; Vale W
Endocrinology; 1983 Sep; 113(3):866-70. PubMed ID: 6307669
[TBL] [Abstract][Full Text] [Related]
18. [Antiglucocorticoid action of RU 486].
Bertagna X
Ann Endocrinol (Paris); 1989; 50(3):208-17. PubMed ID: 2554782
[TBL] [Abstract][Full Text] [Related]
19. Peripheral antiglucocorticoid action of RU 486 in man.
Bertagna X; Basin C; Picard F; Varet B; Bertagna C; Hucher M; Luton JP
Clin Endocrinol (Oxf); 1988 May; 28(5):537-41. PubMed ID: 3214945
[TBL] [Abstract][Full Text] [Related]
20. Pituitary-adrenal response to RU 486 in man.
Bertagna X
Psychoneuroendocrinology; 1997; 22 Suppl 1():S51-5. PubMed ID: 9264147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
